Dimerization of matrix protein is required for budding of respiratory syncytial virus

Journal of Virology

Volumn 89, Issue 8, 2015, Pages 4624-4635

  Förster, Andreas ^a   Maertens, Goedele N ^a   Farrell, Paul J ^a   Bajorek, Monika ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IN VITRO STUDY; LIGHT SCATTERING; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN STRUCTURE; VIRUS ASSEMBLY; VIRUS LIKE AGENT; VIRUS RELEASE; CHEMICAL STRUCTURE; CONFOCAL MICROSCOPY; CRYSTALLIZATION; GENETICS; METABOLISM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONFORMATION; SIZE EXCLUSION CHROMATOGRAPHY; VIRUS REPLICATION; WESTERN BLOTTING;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; CRYSTALLIZATION; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84925424669     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03500-14     Document Type: Article

References (37)

1. Guvenel AK, Chiu C, Openshaw PJ. 2014. Current concepts and progress in RSV vaccine development. Expert Rev Vaccines 13:333-344. http://dx.doi.org/10.1586/14760584.2014.878653.
2. Collins PL, Graham BS. 2008. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82:2040-2055. http://dx.doi.org/10.1128/JVI.01625-07.
3. Garcia J, Garcia-Barreno B, Vivo A, Melero JA. 1993. Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. Virology 195:243-247. http://dx.doi.org/10.1006/viro.1993.1366.
4. Carromeu C, Simabuco FM, Tamura RE, Farinha Arcieri LE, Ventura AM. 2007. Intracellular localization of human respiratory syncytial virus L protein. Arch Virol 152:2259-2263. http://dx.doi.org/10.1007/s00705-007-1048-4.
5. Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J. 2002. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol 83:753-757.
6. Garcia-Barreno B, Delgado T, Melero JA. 1996. Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J Virol 70:801-808.
7. Li D, Jans DA, Bardin PG, Meanger J, Mills J, Ghildyal R. 2008. Association of respiratory syncytial virusMprotein with viral nucleocapsids is mediated by the M2-1 protein. J Virol 82:8863-8870. http://dx.doi.org/10.1128/JVI.00343-08.
8. Lindquist ME, Lifland AW, Utley TJ, Santangelo PJ, Crowe JE, Jr. 2010. Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol 84:12274-12284. http://dx.doi.org/10.1128/JVI.00260-10.
9. Lifland AW, Jung J, Alonas E, Zurla C, Crowe JE, Jr, Santangelo PJ. 2012. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 86:8245-8258. http://dx.doi.org/10.1128/JVI.00215-12.
10. Roberts SR, Compans RW, Wertz GW. 1995. Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol 69:2667-2673.
11. Teng MN, Collins PL. 1998. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol 72:5707-5716.
12. Shaikh FY, Cox RG, Lifland AW, Hotard AL, Williams JV, Moore ML, Santangelo PJ, Crowe JE, Jr. 2012. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. mBio 3(1): e00270-11. http://dx.doi.org/10.1128/mBio.00270-11.
13. Ghildyal R, Ho A, Jans DA. 2006. Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol Rev 30:692-705. http://dx.doi.org/10.1111/j.1574-6976.2006.00025.x.
14. Kiss G, Holl JM, Williams GM, Alonas E, Vanover D, Lifland AW, Gudheti M, Guerrero-Ferreira RC, Nair V, Yi H, Graham BS, Santangelo PJ, Wright ER. 2014. Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J Virol 88:7602-7617. http://dx.doi.org/10.1128/JVI.00256-14.
15. Mitra R, Baviskar P, Duncan-Decocq RR, Patel D, Oomens AG. 2012. The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J Virol 86:4432-4443. http://dx.doi.org/10.1128/JVI.06744-11.
16. Ghildyal R, Baulch-Brown C, Mills J, Meanger J. 2003. The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch Virol 148:1419-1429.
17. Baviskar PS, Hotard AL, Moore ML, Oomens AG. 2013. The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. J Virol 87:10730-10741. http://dx.doi.org/10.1128/JVI.03086-12.
18. Liljeroos L, Krzyzaniak MA, Helenius A, Butcher SJ. 2013. Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A 110:11133-11138. http://dx.doi.org/10.1073/pnas.1309070110.
19. McPhee HK, Carlisle JL, Beeby A, Money VA, Watson SM, Yeo RP, Sanderson JM. 2011. Influence of lipids on the interfacial disposition of respiratory syncytical virus matrix protein. Langmuir 27:304-311. http://dx.doi.org/10.1021/la104041n.
20. Bajorek M, Caly L, Tran KC, Maertens GN, Tripp RA, Bacharach E, Teng MN, Ghildyal R, Jans DA. 2014. The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production. J Virol 88:6380-6393. http://dx.doi.org/10.1128/JVI.03856-13.
21. Dessen A, Volchkov V, Dolnik O, Klenk HD, Weissenhorn W. 2000. Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J 19:4228-4236. http://dx.doi.org/10.1093/emboj/19.16.4228.
22. Neumann P, Lieber D, Meyer S, Dautel P, Kerth A, Kraus I, Garten W, Stubbs MT. 2009. Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties. Proc Natl Acad Sci U S A 106:3710-3715. http://dx.doi.org/10.1073/pnas.0808101106.
23. Battisti AJ, Meng G, Winkler DC, McGinnes LW, Plevka P, Steven AC, Morrison TG, Rossmann MG. 2012. Structure and assembly of a paramyxovirus matrix protein. Proc Natl Acad Sci U S A 109:13996-14000. http://dx.doi.org/10.1073/pnas.1210275109.
24. Leyrat C, Renner M, Harlos K, Huiskonen JT, Grimes JM. 2014. Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure 22:136-148. http://dx.doi.org/10.1016/j.str.2013.10.013.
25. Money VA, McPhee HK, Mosely JA, Sanderson JM, Yeo RP. 2009. Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction. Proc Natl Acad Sci U S A 106:4441-4446. http://dx.doi.org/10.1073/pnas.0805740106.
26. Sheldrick GM. 2008. A short history of SHELX. Acta Crystallogr A 64: 112-122. http://dx.doi.org/10.1107/S0108767307043930.
27. Foadi J, Aller P, Alguel Y, Cameron A, Axford D, Owen RL, Armour W, Waterman DG, Iwata S, Evans G. 2013. Clustering procedures for the optimal selection of data sets from multiple crystals in macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 69:1617-1632. http://dx.doi.org/10.1107/S0907444913012274.
28. Kabsch W. 2010. Xds. Acta Crystallogr D Biol Crystallogr 66:125-132. http://dx.doi.org/10.1107/S0907444909047337.
29. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40: 658-674. http://dx.doi.org/10.1107/S0021889807021206.
30. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA. 2011. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67:355-367. http://dx.doi.org/10.1107/S0907444911001314.
31. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221. http://dx.doi.org/10.1107/S0907444909052925.
32. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501. http://dx.doi.org/10.1107/S0907444910007493.
33. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797. http://dx.doi.org/10.1016/j.jmb.2007.05.022.
34. Lambert DM, Hambor J, Diebold M, Galinski B. 1988. Kinetics of synthesis and phosphorylation of respiratory syncytial virus polypeptides. J Gen Virol 69(Pt 2):313-323. http://dx.doi.org/10.1099/0022-1317-69-2-313.
35. Shahrabadi MS, Lee PW. 1988. Calcium requirement for syncytium formation in HEp-2 cells by respiratory syncytial virus. J Clin Microbiol 26:139-141.
36. Ghildyal R, Ho A, Dias M, Soegiyono L, Bardin PG, Tran KC, Teng MN, Jans DA. 2009. The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. J Virol 83:5353-5362. http://dx.doi.org/10.1128/JVI.02374-08.
37. Harrison MS, Sakaguchi T, Schmitt AP. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 42:1416-1429. http://dx.doi.org/10.1016/j.biocel.2010.04.005.